TreeWAS – Variant ID: rs12302103

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z88.6 Personal history of allergy to analgesic agent	0.000	0.932	0.068
T14.0 Superficial injury of unspecified body region	0.021	0.979	0.000
Y85.0 Sequelae of motor-vehicle accident	0.000	0.979	0.021
F03 Unspecified dementia	0.000	0.983	0.017
T42.4 Benzodiazepines	0.013	0.987	0.000
T14 Injury of unspecified body region	0.013	0.987	0.000
D69.6 Thrombocytopenia, unspecified	0.000	0.987	0.013
T14.9 Injury, unspecified	0.010	0.989	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.010	0.990	0.000
T14.4 Injury of nerve(s) of unspecified body region	0.010	0.990	0.000
T14.6 Injury of tendons and muscles of unspecified body region	0.010	0.990	0.000
T14.2 Fracture of unspecified body region	0.009	0.990	0.000
T14.8 Other injuries of unspecified body region	0.009	0.990	0.000
T14.7 Crushing injury and traumatic amputation of unspecified body region	0.009	0.990	0.000
T14.5 Injury of blood vessel(s) of unspecified body region	0.009	0.990	0.000
T14.3 Dislocation, sprain and strain of unspecified body region	0.009	0.990	0.000
T14.1 Open wound of unspecified body region	0.009	0.991	0.000
N60.3 Fibrosclerosis of breast	0.000	0.991	0.009
Y85 Sequelae of transport accidents	0.000	0.991	0.009
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.009	0.991	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.008	0.992	0.000
K63.3 Ulcer of intestine	0.008	0.992	0.000
T42.1 Iminostilbenes	0.008	0.992	0.000
T42.3 Barbiturates	0.008	0.992	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.008	0.992	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.008	0.992	0.000
T42.2 Succinimides and oxazolidinediones	0.008	0.992	0.000
T14.21 Fracture of unspecified body region (open)	0.007	0.993	0.000
T14.20 Fracture of unspecified body region (closed)	0.007	0.993	0.000
R22.9 Localised swelling, mass and lump, unspecified	0.000	0.993	0.007
E10.9 Without complications	0.000	0.993	0.007
Y85.9 Sequelae of other and unspecified transport accidents	0.000	0.994	0.006
T42.0 Hydantoin derivatives	0.006	0.994	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.000	0.995	0.005
F29 Unspecified nonorganic psychosis	0.000	0.995	0.005
E10.3 With ophthalmic complications	0.000	0.995	0.005
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
Z36.9 Antenatal screening, unspecified	0.000	0.995	0.005
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.005	0.995	0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.000	0.995	0.005
E10 Insulin-dependent diabetes mellitus	0.000	0.995	0.005
T40.2 Other opioids	0.005	0.995	0.000
T36 Poisoning by systemic antibiotics	0.005	0.995	0.000
F25 Schizoaffective disorders	0.000	0.995	0.005
T43.0 Tricyclic and tetracyclic antidepressants	0.005	0.995	0.000
D69 Purpura and other haemorrhagic conditions	0.000	0.995	0.005
R44.3 Hallucinations, unspecified	0.005	0.995	0.000
F22 Persistent delusional disorders	0.000	0.995	0.004
E10.8 With unspecified complications	0.000	0.996	0.004
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
C92.0 Acute myeloid leukaemia	0.000	0.996	0.004
T40.4 Other synthetic narcotics	0.004	0.996	0.000
T36.0 Penicillins	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
E10.2 With renal complications	0.000	0.996	0.004
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
I84.5 External haemorrhoids without complication	0.000	0.996	0.004
F22.0 Delusional disorder	0.000	0.996	0.004
F23 Acute and transient psychotic disorders	0.000	0.996	0.004
T40.5 Cocaine	0.004	0.996	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
F09 Unspecified organic or symptomatic mental disorder	0.000	0.996	0.004
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.000	0.996	0.004
E10.6 With other specified complications	0.000	0.996	0.004
F25.9 Schizoaffective disorder, unspecified	0.000	0.996	0.004
F25.0 Schizoaffective disorder, manic type	0.000	0.996	0.004
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.996	0.000
F25.1 Schizoaffective disorder, depressive type	0.000	0.996	0.004
T36.3 Macrolides	0.004	0.996	0.000
F01 Vascular dementia	0.000	0.996	0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.004	0.996	0.000
D69.0 Allergic purpura	0.000	0.996	0.004
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.000	0.996	0.004
F23.9 Acute and transient psychotic disorder, unspecified	0.000	0.996	0.004
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.004	0.996	0.000
T40.8 Lysergide [LSD]	0.004	0.996	0.000
T40.7 Cannabis (derivatives)	0.004	0.996	0.000
T40.3 Methadone	0.004	0.996	0.000
T40.1 Heroin	0.004	0.996	0.000
T40.0 Opium	0.004	0.996	0.000
S72.00 Fracture of neck of femur (closed)	0.000	0.996	0.004
T43.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.996	0.000
F28 Other nonorganic psychotic disorders	0.000	0.996	0.004
F24 Induced delusional disorder	0.000	0.996	0.004
F21 Schizotypal disorder	0.000	0.996	0.004
E10.7 With multiple complications	0.000	0.996	0.004
F02 Dementia in other diseases classified elsewhere	0.000	0.996	0.004
S82.30 Fracture of lower end of tibia (closed)	0.004	0.996	0.000
T36.9 Systemic antibiotic, unspecified	0.004	0.996	0.000
T36.8 Other systemic antibiotics	0.004	0.996	0.000
T36.7 Antifungal antibiotics, systemically used	0.004	0.996	0.000
T36.6 Rifamycins	0.004	0.996	0.000
T36.5 Aminoglycosides	0.004	0.996	0.000
T36.4 Tetracyclines	0.004	0.996	0.000
T36.2 Chloramphenicol group	0.004	0.996	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.004	0.996	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.004	0.996	0.000
F05 Delirium, not induced by alcohol and other psychoactive substances	0.000	0.996	0.004
F25.8 Other schizoaffective disorders	0.000	0.996	0.004
F25.2 Schizoaffective disorder, mixed type	0.000	0.996	0.004
E10.4 With neurological complications	0.000	0.996	0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.000	0.996	0.004
T47.4 Other laxatives	0.004	0.996	0.000
E10.0 With coma	0.000	0.996	0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
D69.8 Other specified haemorrhagic conditions	0.000	0.996	0.003
K04.8 Radicular cyst	0.000	0.996	0.004
T40.6 Other and unspecified narcotics	0.003	0.996	0.000
D69.2 Other nonthrombocytopenic purpura	0.000	0.996	0.003
F22.8 Other persistent delusional disorders	0.000	0.996	0.003
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
Z36 Antenatal screening	0.000	0.996	0.004
T45.0 Antiallergic and antiemetic drugs	0.003	0.996	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.996	0.000
F22.9 Persistent delusional disorder, unspecified	0.000	0.997	0.003
F00 Dementia in Alzheimer's disease	0.000	0.997	0.003
D69.9 Haemorrhagic condition, unspecified	0.000	0.997	0.003
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
F05.8 Other delirium	0.000	0.997	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
T43.9 Psychotropic drug, unspecified	0.003	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
F23.8 Other acute and transient psychotic disorders	0.000	0.997	0.003
F23.3 Other acute predominantly delusional psychotic disorders	0.000	0.997	0.003
F23.2 Acute schizophrenia-like psychotic disorder	0.000	0.997	0.003
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia	0.000	0.997	0.003
D69.1 Qualitative platelet defects	0.000	0.997	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.997	0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.997	0.000
Z36.8 Other antenatal screening	0.000	0.997	0.003
M94.86 Other specified disorders of cartilage (Lower leg)	0.000	0.997	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
F01.8 Other vascular dementia	0.000	0.997	0.003
F01.3 Mixed cortical and subcortical vascular dementia	0.000	0.997	0.003
F01.2 Subcortical vascular dementia	0.000	0.997	0.003
F01.1 Multi-infarct dementia	0.000	0.997	0.003
F01.0 Vascular dementia of acute onset	0.000	0.997	0.003
T12.X1 Fracture of lower limb, level unspecified (open)	0.003	0.997	0.000
T12.X0 Fracture of lower limb, level unspecified (closed)	0.003	0.997	0.000
T12 Fracture of lower limb, level unspecified	0.003	0.997	0.000
T10.X1 Fracture of upper limb, level unspecified (open)	0.003	0.997	0.000
T10.X0 Fracture of upper limb, level unspecified (closed)	0.003	0.997	0.000
T10 Fracture of upper limb, level unspecified	0.003	0.997	0.000
T08.X1 Fracture of spine, level unspecified (open)	0.003	0.997	0.000
T08.X0 Fracture of spine, level unspecified (closed)	0.003	0.997	0.000
T08 Fracture of spine, level unspecified	0.003	0.997	0.000
F02.0 Dementia in Pick's disease	0.000	0.997	0.003
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction	0.000	0.997	0.003
F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction	0.000	0.997	0.003
F07.1 Postencephalitic syndrome	0.000	0.997	0.003
F07.0 Organic personality disorder	0.000	0.997	0.003
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.997	0.003
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.000	0.997	0.003
D69.4 Other primary thrombocytopenia	0.000	0.997	0.003
F99 Mental disorder, not otherwise specified	0.000	0.997	0.003
F20.0 Paranoid schizophrenia	0.000	0.997	0.003
T43.6 Psychostimulants with abuse potential	0.003	0.997	0.000
T90.4 Sequelae of injury of eye and orbit	0.000	0.997	0.003
F01.9 Vascular dementia, unspecified	0.000	0.997	0.003
H20.8 Other iridocyclitis	0.000	0.997	0.003
O36.5 Maternal care for poor foetal growth	0.003	0.997	0.000
T45.5 Anticoagulants	0.003	0.997	0.000
F20 Schizophrenia	0.000	0.997	0.003
F99-F99 Unspecified mental disorder	0.000	0.997	0.003
F07.2 Postconcussional syndrome	0.000	0.997	0.003
T43.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
D69.5 Secondary thrombocytopenia	0.000	0.997	0.003
F02.4 Dementia in human immunodeficiency virus [HIV] disease	0.000	0.997	0.003
F02.2 Dementia in Huntington's disease	0.000	0.997	0.003
F02.1 Dementia in Creutzfeldt-Jakob disease	0.000	0.997	0.003
K13.7 Other and unspecified lesions of oral mucosa	0.003	0.997	0.000
T11 Other injuries of upper limb, level unspecified	0.003	0.997	0.000
T09 Other injuries of spine and trunk, level unspecified	0.003	0.997	0.000
Chapter V Mental and behavioural disorders	0.000	0.997	0.003
M22.4 Chondromalacia patellae	0.003	0.997	0.000
M79.79 Fibromyalgia (Site unspecified)	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
R44 Other symptoms and signs involving general sensations and perceptions	0.003	0.997	0.000
E10.1 With ketoacidosis	0.000	0.997	0.003
F00.0 Dementia in Alzheimer's disease with early onset	0.000	0.997	0.003
T39.0 Salicylates	0.003	0.997	0.000
F02.8 Dementia in other specified diseases classified elsewhere	0.000	0.997	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
H16.0 Corneal ulcer	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000
T50.5 Appetite depressants	0.003	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.003	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.997	0.000
T13 Other injuries of lower limb, level unspecified	0.003	0.997	0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia	0.000	0.997	0.003
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.997	0.003
R44.0 Auditory hallucinations	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
Z36.5 Antenatal screening for isoimmunisation	0.000	0.997	0.003
F05.9 Delirium, unspecified	0.000	0.997	0.003
F00.1 Dementia in Alzheimer's disease with late onset	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Z39.2 Routine postpartum follow-up	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.997	0.000
T90.2 Sequelae of fracture of skull and facial bones	0.000	0.997	0.003
H16.8 Other keratitis	0.003	0.997	0.000
F05.0 Delirium not superimposed on dementia, so described	0.000	0.997	0.002
T43.5 Other and unspecified antipsychotics and neuroleptics	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
M94.8 Other specified disorders of cartilage	0.000	0.997	0.003
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.000	0.997	0.002
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.000	0.997	0.002
F06.6 Organic emotionally labile [asthenic] disorder	0.000	0.997	0.002
F06.5 Organic dissociative disorder	0.000	0.997	0.002
F06.4 Organic anxiety disorder	0.000	0.997	0.002
F06.3 Organic mood [affective] disorders	0.000	0.997	0.002
F06.1 Organic catatonic disorder	0.000	0.997	0.002
F06.0 Organic hallucinosis	0.000	0.997	0.002
T90.5 Sequelae of intracranial injury	0.000	0.997	0.003
H16 Keratitis	0.003	0.997	0.000
E10.5 With peripheral circulatory complications	0.000	0.997	0.002
R44.1 Visual hallucinations	0.003	0.997	0.000
T90 Sequelae of injuries of head	0.000	0.997	0.003
F70-F79 Mental retardation	0.000	0.997	0.002
F40.2 Specific (isolated) phobias	0.000	0.997	0.002
F20.6 Simple schizophrenia	0.000	0.998	0.002
F20.4 Postschizophrenic depression	0.000	0.998	0.002
F20.3 Undifferentiated schizophrenia	0.000	0.998	0.002
F20.2 Catatonic schizophrenia	0.000	0.998	0.002
F20.1 Hebephrenic schizophrenia	0.000	0.998	0.002
T09.9 Unspecified injury of trunk, level unspecified	0.002	0.998	0.000
T09.8 Other specified injuries of trunk, level unspecified	0.002	0.998	0.000
T09.6 Traumatic amputation of trunk, level unspecified	0.002	0.998	0.000
T09.5 Injury of unspecified muscle and tendon of trunk	0.002	0.998	0.000
T09.4 Injury of unspecified nerve, spinal nerve root and plexus of trunk	0.002	0.998	0.000
T09.3 Injury of spinal cord, level unspecified	0.002	0.998	0.000
T09.2 Dislocation, strain and sprain of unspecified joint and ligament of trunk	0.002	0.998	0.000
T09.1 Open wound of trunk, level unspecified	0.002	0.998	0.000
T11.9 Unspecified injury of upper limb, level unspecified	0.002	0.998	0.000
T11.8 Other specified injuries of upper limb, level unspecified	0.002	0.998	0.000
T11.6 Traumatic amputation of upper limb, level unspecified	0.002	0.998	0.000
T11.5 Injury of unspecified muscle and tendon of upper limb, level unspecified	0.002	0.998	0.000
T11.4 Injury of unspecified blood vessel of upper limb, level unspecified	0.002	0.998	0.000
T11.3 Injury of unspecified nerve of upper limb, level unspecified	0.002	0.998	0.000
T11.2 Dislocation, strain and sprain of unspecified joint and ligament of upper limb, level unspecified	0.002	0.998	0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.000	0.998	0.002
M71.38 Other bursal cyst (Other)	0.000	0.998	0.002
F02.3 Dementia in Parkinson's disease	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.998	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.998	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
T44.0 Anticholinesterase agents	0.002	0.998	0.000
F80-F89 Disorders of psychological development	0.000	0.998	0.002
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.000	0.998	0.002
R44.2 Other hallucinations	0.002	0.998	0.000
T11.1 Open wound of upper limb, level unspecified	0.002	0.998	0.000
F06.2 Organic delusional [schizophrenia-like] disorder	0.000	0.998	0.002
H16.9 Keratitis, unspecified	0.002	0.998	0.000
N89.5 Stricture and atresia of vagina	0.000	0.998	0.002
F05.1 Delirium superimposed on dementia	0.000	0.998	0.002
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.998	0.002
T46 Poisoning by agents primarily affecting the cardiovascular system	0.002	0.998	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.000	0.998	0.002
T13.9 Unspecified injury of lower limb, level unspecified	0.002	0.998	0.000
T13.8 Other specified injuries of lower limb, level unspecified	0.002	0.998	0.000
T13.6 Traumatic amputation of lower limb, level unspecified	0.002	0.998	0.000
T13.5 Injury of unspecified muscle and tendon of lower limb, level unspecified	0.002	0.998	0.000
T13.4 Injury of unspecified blood vessel of lower limb, level unspecified	0.002	0.998	0.000
T13.3 Injury of unspecified nerve of lower limb, level unspecified	0.002	0.998	0.000
T13.2 Dislocation, strain and sprain of unspecified joint and ligament of lower limb, level unspecified	0.002	0.998	0.000
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)	0.000	0.998	0.002
T13.1 Open wound of lower limb, level unspecified	0.002	0.998	0.000
T90.8 Sequelae of other specified injuries of head	0.000	0.998	0.002
C91.1 Chronic lymphocytic leukaemia	0.002	0.998	0.000
R44.8 Other and unspecified symptoms and signs involving general sensations and perceptions	0.002	0.998	0.000
T11.0 Superficial injury of upper limb, level unspecified	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.002	0.998	0.000
T09.0 Superficial injury of trunk, level unspecified	0.002	0.998	0.000
M94.89 Other specified disorders of cartilage (Site unspecified)	0.000	0.998	0.002
F11.2 Dependence syndrome	0.000	0.998	0.002
M79.60 Pain in limb (Multiple sites)	0.000	0.998	0.002
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.998	0.002
M94.88 Other specified disorders of cartilage (Other)	0.000	0.998	0.002
H16.2 Keratoconjunctivitis	0.002	0.998	0.000
T39.1 4-Aminophenol derivatives	0.002	0.998	0.000
F84 Pervasive developmental disorders	0.000	0.998	0.002
Y85-Y89 Sequelae of external causes of morbidity and mortality	0.000	0.998	0.002
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.002	0.998	0.000
F40 Phobic anxiety disorders	0.000	0.998	0.002
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.000	0.998	0.002
M94.84 Other specified disorders of cartilage (Hand)	0.000	0.998	0.002
M94.83 Other specified disorders of cartilage (Forearm)	0.000	0.998	0.002
M94.82 Other specified disorders of cartilage (Upper arm)	0.000	0.998	0.002
M94.81 Other specified disorders of cartilage (Shoulder region)	0.000	0.998	0.002
M94.80 Other specified disorders of cartilage (Multiple sites)	0.000	0.998	0.002
R46.4 Slowness and poor responsiveness	0.002	0.998	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.000	0.998	0.002
F20.5 Residual schizophrenia	0.000	0.998	0.002
H16.4 Corneal neovascularisation	0.002	0.998	0.000
H16.3 Interstitial and deep keratitis	0.002	0.998	0.000
F79 Unspecified mental retardation	0.000	0.998	0.002
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.002	0.998	0.000
F20.8 Other schizophrenia	0.000	0.998	0.002
F31.9 Bipolar affective disorder, unspecified	0.000	0.998	0.002
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent	0.000	0.998	0.002
F81 Specific developmental disorders of scholastic skills	0.000	0.998	0.002
F78 Other mental retardation	0.000	0.998	0.002
F73 Profound mental retardation	0.000	0.998	0.002
F72 Severe mental retardation	0.000	0.998	0.002
F71 Moderate mental retardation	0.000	0.998	0.002
F70 Mild mental retardation	0.000	0.998	0.002
F84.5 Asperger's syndrome	0.000	0.998	0.002
T90.9 Sequelae of unspecified injury of head	0.000	0.998	0.002
F45.8 Other somatoform disorders	0.000	0.998	0.002
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.000	0.998	0.002
F95 Tic disorders	0.000	0.998	0.002
F94 Disorders of social functioning with onset specific to childhood and adolescence	0.000	0.998	0.002
F93 Emotional disorders with onset specific to childhood	0.000	0.998	0.002
F92 Mixed disorders of conduct and emotions	0.000	0.998	0.002
F91 Conduct disorders	0.000	0.998	0.002
F90 Hyperkinetic disorders	0.000	0.998	0.002
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.002	0.998	0.000
K63.2 Fistula of intestine	0.000	0.998	0.002
T13.0 Superficial injury of lower limb, level unspecified	0.002	0.998	0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.002	0.998	0.000
S72.0 Fracture of neck of femur	0.000	0.998	0.002
F89 Unspecified disorder of psychological development	0.000	0.998	0.002
F88 Other disorders of psychological development	0.000	0.998	0.002
F83 Mixed specific developmental disorders	0.000	0.998	0.002
F82 Specific developmental disorder of motor function	0.000	0.998	0.002
H20 Iridocyclitis	0.000	0.998	0.002
S42.10 Fracture of scapula (closed)	0.000	0.998	0.002
F40-F48 Neurotic, stress-related and somatoform disorders	0.000	0.998	0.002
M21.47 Flat foot [pes planus] (acquired)-Ankle/foot	0.002	0.998	0.000
Z90.6 Acquired absence of other parts of urinary tract	0.000	0.998	0.002
H20.9 Iridocyclitis, unspecified	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.000	0.998	0.002
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors	0.000	0.998	0.002
F55 Abuse of non-dependence-producing substances	0.000	0.998	0.002
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere	0.000	0.998	0.002
M77.47 Metatarsalgia-Ankle/Foot	0.000	0.998	0.002
K04.9 Other and unspecified diseases of pulp and periapical tissues	0.000	0.998	0.002
T90.3 Sequelae of injury of cranial nerves	0.000	0.998	0.002
Y89 Sequelae of other external causes	0.000	0.998	0.002
I87.1 Compression of vein	0.000	0.998	0.002
F52 Sexual dysfunction, not caused by organic disorder or disease	0.000	0.998	0.002
L81.4 Other melanin hyperpigmentation	0.002	0.998	0.000
F51 Nonorganic sleep disorders	0.000	0.998	0.002
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.002	0.998	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.002	0.998	0.000
F40.0 Agoraphobia	0.000	0.998	0.002
R46.2 Strange and inexplicable behaviour	0.002	0.998	0.000
Y87.2 Sequelae of events of undetermined intent	0.000	0.998	0.002
Y87.1 Sequelae of assault	0.000	0.998	0.002
N87.9 Dysplasia of cervix uteri, unspecified	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
F50 Eating disorders	0.000	0.998	0.002
F84.9 Pervasive developmental disorder, unspecified	0.000	0.998	0.002
F84.8 Other pervasive developmental disorders	0.000	0.998	0.002
F84.4 Overactive disorder associated with mental retardation and stereotyped movements	0.000	0.998	0.002
F84.3 Other childhood disintegrative disorder	0.000	0.998	0.002
F84.2 Rett's syndrome	0.000	0.998	0.002
F84.1 Atypical autism	0.000	0.998	0.002
F84.0 Childhood autism	0.000	0.998	0.002
F40.1 Social phobias	0.000	0.998	0.002
H20.1 Chronic iridocyclitis	0.000	0.998	0.002
R46.0 Very low level of personal hygiene	0.002	0.998	0.000
F40.8 Other phobic anxiety disorders	0.000	0.998	0.002
F79.9 Unspecified mental retardation (Without mention of impairment of behaviour)	0.000	0.998	0.002
M24.07 Loose body in joint (Ankle and foot)	0.002	0.998	0.000
F06.7 Mild cognitive disorder	0.000	0.998	0.002
F81.9 Developmental disorder of scholastic skills, unspecified	0.000	0.998	0.002
T90.0 Sequelae of superficial injury of head	0.000	0.998	0.002
Y87.0 Sequelae of intentional self-harm	0.000	0.998	0.002
F31 Bipolar affective disorder	0.002	0.998	0.000
F79.8 Unspecified mental retardation (Other impairments of behaviour)	0.000	0.998	0.002
F79.1 Unspecified mental retardation (Significant impairment of behaviour requiring attention or treatment)	0.000	0.998	0.002
F79.0 Unspecified mental retardation (With the statement of no, or minimal, impairment of behaviour)	0.000	0.998	0.002
T90.1 Sequelae of open wound of head	0.000	0.998	0.002
F70.9 Mild mental retardation (Without mention of impairment of behaviour)	0.000	0.998	0.001
F70.8 Mild mental retardation (Other impairments of behaviour)	0.000	0.998	0.001
F70.1 Mild mental retardation (Significant impairment of behaviour requiring attention or treatment)	0.000	0.998	0.001
F70.0 Mild mental retardation (With the statement of no, or minimal, impairment of behaviour)	0.000	0.998	0.001
F71.9 Moderate mental retardation (Without mention of impairment of behaviour)	0.000	0.998	0.001
F71.8 Moderate mental retardation (Other impairments of behaviour)	0.000	0.998	0.001
F71.1 Moderate mental retardation (Significant impairment of behaviour requiring attention or treatment)	0.000	0.998	0.001
F71.0 Moderate mental retardation (With the statement of no, or minimal, impairment of behaviour)	0.000	0.998	0.001
F72.9 Severe mental retardation (Without mention of impairment of behaviour)	0.000	0.998	0.001
F72.8 Severe mental retardation (Other impairments of behaviour)	0.000	0.998	0.001
F72.1 Severe mental retardation (Significant impairment of behaviour requiring attention or treatment)	0.000	0.998	0.001
F72.0 Severe mental retardation (With the statement of no, or minimal, impairment of behaviour)	0.000	0.998	0.001
F73.9 Profound mental retardation (Without mention of impairment of behaviour)	0.000	0.998	0.001
F73.8 Profound mental retardation (Other impairments of behaviour)	0.000	0.998	0.001
F73.1 Profound mental retardation (Significant impairment of behaviour requiring attention or treatment)	0.000	0.998	0.001
F73.0 Profound mental retardation (With the statement of no, or minimal, impairment of behaviour)	0.000	0.998	0.001
F78.9 Other mental retardation (Without mention of impairment of behaviour)	0.000	0.998	0.001
F78.8 Other mental retardation (Other impairments of behaviour)	0.000	0.998	0.001
F78.1 Other mental retardation (Significant impairment of behaviour requiring attention or treatment)	0.000	0.998	0.001
F78.0 Other mental retardation (With the statement of no, or minimal, impairment of behaviour)	0.000	0.998	0.001
F81.8 Other developmental disorders of scholastic skills	0.000	0.998	0.002
F81.3 Mixed disorder of scholastic skills	0.000	0.998	0.002
F81.2 Specific disorder of arithmetical skills	0.000	0.998	0.002
F81.1 Specific spelling disorder	0.000	0.998	0.002
F81.0 Specific reading disorder	0.000	0.998	0.002
L40.9 Psoriasis, unspecified	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.001	0.998	0.000
Y89.9 Sequelae of unspecified external cause	0.000	0.998	0.002
F31.0 Bipolar affective disorder, current episode hypomanic	0.002	0.998	0.000
F90.9 Hyperkinetic disorder, unspecified	0.000	0.998	0.001
F90.8 Other hyperkinetic disorders	0.000	0.998	0.001
F90.1 Hyperkinetic conduct disorder	0.000	0.998	0.001
F90.0 Disturbance of activity and attention	0.000	0.998	0.001
F91.9 Conduct disorder, unspecified	0.000	0.998	0.001
F91.8 Other conduct disorders	0.000	0.998	0.001
F91.3 Oppositional defiant disorder	0.000	0.998	0.001
F91.2 Socialised conduct disorder	0.000	0.998	0.001
F91.1 Unsocialised conduct disorder	0.000	0.998	0.001
F91.0 Conduct disorder confined to the family context	0.000	0.998	0.001
F92.9 Mixed disorder of conduct and emotions, unspecified	0.000	0.998	0.001
F92.8 Other mixed disorders of conduct and emotions	0.000	0.998	0.001
F92.0 Depressive conduct disorder	0.000	0.998	0.001
F93.9 Childhood emotional disorder, unspecified	0.000	0.998	0.001
F93.8 Other childhood emotional disorders	0.000	0.998	0.001
F93.3 Sibling rivalry disorder	0.000	0.998	0.001
F93.2 Social anxiety disorder of childhood	0.000	0.998	0.001
F93.1 Phobic anxiety disorder of childhood	0.000	0.998	0.001
F93.0 Separation anxiety disorder of childhood	0.000	0.998	0.001
F94.9 Childhood disorder of social functioning, unspecified	0.000	0.998	0.001
F94.8 Other childhood disorders of social functioning	0.000	0.998	0.001
F94.2 Disinhibited attachment disorder of childhood	0.000	0.998	0.001
F94.1 Reactive attachment disorder of childhood	0.000	0.998	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations